SCHEMBL7251894

SCHEMBL7251894

O=C1/C(=C/c2ccccc2)SC(c2cccc(C(F)(F)F)c2)N1CCCN1CCN(c2ccccn2)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD3 P35462 3/20 0.47
DRD2 P14416 2/20 0.47
DRD1 P21728 2/20 0.47
ALDH1A1 P00352 3/20 0.45
LMNA P02545 2/20 0.45
HSD17B10 Q99714 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
CACNA1B Q00975 1/20 0.43
KDM4E B2RXH2 3/20 0.42
HTR7 P34969 2/20 0.42
MAPT P10636 1/20 0.42
KCNH2 Q12809 2/20 0.41
POLB P06746 1/20 0.41
ADRA1A P35348 1/20 0.41
HTR1A P08908 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7251895 1.00 DRD3 (0.47) DRD3DRD2DRD1ALDH1A1LMNA
SCHEMBL7248324 0.93 CACNA1B (0.42) DRD3DRD2DRD1CACNA1BHTR7
SCHEMBL7248322 0.93 CACNA1B (0.42) DRD3DRD2DRD1CACNA1BHTR7
SCHEMBL7252877 0.92 DRD2 (0.43) DRD3DRD2DRD1ALDH1A1LMNA
SCHEMBL7252876 0.92 DRD2 (0.43) DRD3DRD2DRD1ALDH1A1LMNA
SCHEMBL7248930 0.89 HTR7 (0.49) DRD3DRD2DRD1ALDH1A1LMNA
SCHEMBL7248928 0.89 HTR7 (0.49) DRD3DRD2DRD1ALDH1A1LMNA
SCHEMBL7248265 0.88 DRD4 (0.47) DRD3DRD2HTR7KCNH2POLB
SCHEMBL7248267 0.88 DRD4 (0.47) DRD3DRD2HTR7KCNH2POLB
SCHEMBL7254858 0.86 HTR7 (0.49) DRD3DRD2DRD1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6506751-B1 The compounds are useful in the treatment and prevention of the AIDS virus. Intermediates useful in the preparation of the final products, pharmaceutical compositions containing the final products are also taught. invention is directed to MILLENNIUM PHARMACEUTICALS, INC. 2003-01-14 US claimed